Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 05, 2019

SELL
$2.28 - $7.15 $235,523 - $738,595
-103,300 Closed
0 $0
Q3 2018

Nov 07, 2018

SELL
$3.85 - $7.35 $28,490 - $54,390
-7,400 Reduced 6.68%
103,300 $754,000
Q2 2018

Aug 10, 2018

BUY
$3.7 - $5.65 $3,700 - $5,650
1,000 Added 0.91%
110,700 $410,000
Q1 2018

May 08, 2018

SELL
$3.65 - $5.2 $46,183 - $65,795
-12,653 Reduced 10.34%
109,700 $422,000
Q4 2017

Feb 13, 2018

BUY
$3.4 - $4.15 $79,356 - $96,861
23,340 Added 23.57%
122,353 $440,000
Q3 2017

Nov 07, 2017

BUY
$3.55 - $5.25 $54,993 - $81,327
15,491 Added 18.55%
99,013 $391,000
Q2 2017

Nov 20, 2017

BUY
N/A
83,522
83,522 $425,000

About APPLIED GENETIC TECHNOLOGIES CORP


  • Ticker AGTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,632,200
  • Description
  • Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...
More about AGTC
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.